1. Home
  2. WATT vs INO Comparison

WATT vs INO Comparison

Compare WATT & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energous Corporation

WATT

Energous Corporation

HOLD

Current Price

$14.69

Market Cap

101.8M

Sector

Technology

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$0.97

Market Cap

100.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WATT
INO
Founded
2012
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.8M
100.4M
IPO Year
2014
1999

Fundamental Metrics

Financial Performance
Metric
WATT
INO
Price
$14.69
$0.97
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
228.8K
1.5M
Earning Date
05-13-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
$1,154,009.00
$42,220,086.00
Revenue This Year
$179.91
$20,156.19
Revenue Next Year
$126.54
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.37
52 Week Low
$0.27
$0.96
52 Week High
$36.98
$2.86

Technical Indicators

Market Signals
Indicator
WATT
INO
Relative Strength Index (RSI) 31.24 29.48
Support Level $14.23 N/A
Resistance Level $20.48 $1.24
Average True Range (ATR) 1.31 0.06
MACD -0.15 -0.02
Stochastic Oscillator 5.58 6.28

Price Performance

Historical Comparison
WATT
INO

About WATT Energous Corporation

Energous Corp has developed scalable, over-the-air Wireless Power Network (WPN) technology that integrates semiconductor chipsets, software controls, hardware designs, and antenna systems to enable radio frequency (RF)-based charging for ambient Internet of Things (ambient IoT) devices, transforming supply chain capabilities from limited tracking to overall business intelligence. The WPN technology consists of transmitter systems, receiver integrated circuits, and supporting software designed to deliver power and data to battery-free IoT devices across a range of operating distances and power levels. Its applications include retail sensors, electronic shelf labels (ESLs), asset trackers, air quality monitors, motion detectors, and other monitoring solutions.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Share on Social Networks: